US Pauses $1B in Medicaid Payments to California and Minnesota

The Trump administration is freezing more than $1 billion in federal Medicaid payments to California and Minnesota until the states take more steps to investigate questionable claims. HHS and CMS framed the move as a payment deferral tied to a broader fraud crackdown, not a permanent cut.

For traders, the read-through hits managed care organizations, home-health providers, and anyone with heavy Medi-Cal exposure.

What HHS actually did

For California, the administration is holding back $867.5 million after it examined claims for some in-home care programs and found spending growth that outpaced national trends. CMS is halting $199 million for Minnesota after reviewing claims in 14 high-risk service areas in the state that require further documentation.

These are payment deferrals (not permanent funding cuts) and both states will have the opportunity to provide documentation showing the claims meet federal Medicaid requirements.

Not the first freeze

The Trump administration was already withholding $1.3 billion in Medicaid funding from California since May, and nearly $260 million from Minnesota. That brings cumulative deferrals against the two states well above the headline number from Tuesday.

In May, CMS announced it would defer $1.3 billion in Medicaid funds to California, in what Oz said at the time was the biggest deferral ever made by the agency.

Do you want to see how to make more plays? Do you want to find gains yourself?

Unusual Whales helps you find market opportunities through our market tide, historical options flow, GEX, and much, much more.

Create a free account here to start conquering the market with Unusual Whales.

The political overlay

Tuesday marked the second time Trump targeted the two states’ Democratic governors — California Gov. Gavin Newsom and Minnesota Gov. Tim Walz — for alleged Medicaid fraud in their states, and continues a trend of freezing funding to blue states to crack down on alleged fraud.

Minnesota is pushing back. “CMS touts their new fraud-detection capabilities, yet has not provided data or explanation on how the deferral amount was calculated or what it was based on,” said Minnesota’s temporary commissioner and state Medicaid director John Connolly.

Why the market cares

Medicaid managed care plans book federal matching dollars as revenue. Deferrals do not automatically zero out payments, but they inject timing risk, working-capital pressure, and headline risk into any insurer or provider with meaningful Medi-Cal or Minnesota Medicaid exposure.

Kennedy has said that the campaign is aimed at preventing improper payments instead of recovering them after the fact, with the Administration increasingly using payment deferrals and pre-payment reviews of Medicaid claims. That suggests more deferrals, not fewer, in the coming quarters. For more policy news, see other market coverage here.

Options market and stocks to watch

Watch for volatility in the following Medicaid-exposed names as the deferral drags on and states scramble to produce documentation:

• CNC — Centene is one of the largest Medicaid managed care operators, with heavy Medi-Cal exposure. Watch for headline sensitivity.
• ELV — Elevance Health runs sizable Medicaid books across multiple states. Watch for read-through if the deferral framework spreads.
• MOH — Molina Healthcare is nearly pure-play Medicaid. Watch for the sharpest reaction to any expansion of CMS reviews.
• UNH — UnitedHealth’s Community & State segment is a major Medicaid contractor. Watch for options flow around policy headlines.
• HUM — Humana has smaller Medicaid exposure but is sensitive to broader CMS enforcement posture. Watch for spillover moves.

Want more market intelligence? Create your free Unusual Whales account for options flow, market tide, GEX, and the full toolkit.